Pay to Marwadi

Company Profile

MARKSANS PHARMA LTD.

NSE : MARKSANSBSE : 524404ISIN CODE : INE750C01026Industry : Pharmaceuticals & DrugsHouse : Private
BSE171.25-5.25 (-2.97 % )
PREV CLOSE (Rs.) 176.50
OPEN PRICE (Rs.) 178.75
BID PRICE (QTY) 171.05 (382 )
OFFER PRICE (QTY) 171.40 (1051 )
VOLUME 702535
TODAY'S LOW / HIGH (Rs.)169.05 185.40
52 WK LOW / HIGH (Rs.)70.2 179.1
NSE171.30 -5.4 (-3.06 % )
PREV CLOSE(Rs.) 176.70
OPEN PRICE (Rs.) 178.30
BID PRICE (QTY) 171.15 (833 )
OFFER PRICE (QTY) 171.30 (1519 )
VOLUME 9495196
TODAY'S LOW / HIGH(Rs.) 168.55 185.50
52 WK LOW / HIGH (Rs.)70.55 179.3

Quaterly Results

(Rs in Million)
";
Particulars Dec 2023 Sep 2023 Jun 2023 Mar 2023
Audited / UnAudited UnAudited UnAudited UnAudited UnAudited
Net Sales 5861.27 5312.36 5000.33 4859.76
Total Expenditure 4531.05 4172.87 3980.67 3764.27
PBIDT (Excl OI) 1330.22 1139.49 1019.66 1095.49
Other Income 48 189.96 100.96 110.09
Operating Profit 1378.22 1329.45 1120.62 1205.58
Interest 31.61 16.26 15.76 24.4
Exceptional Items NA NA NA NA
PBDT 1346.61 1313.19 1104.86 1181.18
Depreciation 220.03 175.51 136.6 139.44
Profit Before Tax 1126.58 1137.68 968.26 1041.74
Tax 296.93 299.18 263.88 214.64
Provisions and contingencies NA NA NA NA
Profit After Tax 829.65 838.5 704.38 827.1
Extraordinary Items NA NA NA NA
Prior Period Expenses NA NA NA NA
Other Adjustments NA NA NA NA
Net Profit 829.65 838.5 704.38 827.1
Minority Interest 2.7 -3.32 -17.8 -7.78
Shares of Associates
Other related items
Misc. Expenses Written off NA NA NA NA
Consolidated Net Profit 832.35 835.18 686.58 819.32
Equity Capital 453.16 453.16 453.16 453.16
Face Value (IN RS) 1 1 1 1
Reserves NA NA NA NA
Calculated EPS 1.83 1.84 1.51 1.80
Calculated EPS (Annualised) 7.34 7.37 6.06 7.23
No of Public Share Holdings 254452013 254452013 254452013 254452013
% of Public Share Holdings 56.15 56.15 56.15 56.15
  NA NA NA NA
PBIDTM% (Excl OI) 22.69 21.44 20.39 22.54
PBIDTM% 23.51 25.02 22.41 24.80
PBDTM% 22.97 24.71 22.09 24.30
PBTM% 19.22 21.41 19.36 21.43
PATM% 14.15 15.78 14.08 17.01
 Notes Notes Notes Notes